Fresenius Kabi Oncology is Pharmaceuticals in India that focus on pharmaceutical products business. Founded in 2003. They cover business area such as manufacturer, anti-cancer product, enhanced third generation chemotherapeutic drug, development, manufacturing, marketing, injectable, oral cytotoxic, cytostatic, intermediate, active pharmaceutical ingredient, patient.
2003
( 21 years old in 2024 )
Pharmaceutical Products
-
Echelon Institutional Area
Plot No-11, Sector - 32
Gurgaon, Haryana 122001
India
Private
manufactureranti-cancer productenhanced third generation chemotherapeutic drugdevelopmentmanufacturingmarketinginjectableoral cytotoxiccytostaticintermediateactive pharmaceutical ingredientpatient
* We use standard office opening hours in near Fresenius Kabi Oncology's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Fresenius Kabi Oncology is Pharmaceuticals business from India that founded in 2003 (21 years old in 2024), Fresenius Kabi Oncology business is focusing on Pharmaceutical Products.
Fresenius Kabi Oncology headquarter office and corporate office address is located in Echelon Institutional Area Plot No-11, Sector - 32 Gurgaon, Haryana 122001 India.
Fresenius Kabi Oncology was founded in India.
In 2024, Fresenius Kabi Oncology is currently focus on pharmaceutical products sector.
Above is snippet of Google Trends for "pharmaceutical products" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Fresenius Kabi Oncology, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
